adinazolam mesylate

Networked: 2 relevant articles (1 outcomes, 2 trials/studies)

1.	Panic Disorder (Panic Attack) 02/01/1994 - "Adinazolam mesylate, a triazolobenzodiazepine with antidepressant and anxiolytic activity, has been shown in several studies to treat panic disorder effectively. " 02/01/1994 - "Results indicate that NDMAD contributes to the therapeutic effects of adinazolam mesylate sustained release tablets in the treatment of panic disorder. " 02/01/1994 - "This report presents the results of analysis of concentrations in plasma of adinazolam and its primary metabolite, N-desmethyladinazolam (NDMAD), determined as a part of a flexible-dose, double-blind study of the efficacy of adinazolam mesylate sustained release tablets in the treatment of panic disorder with agoraphobia. "
2.	Agoraphobia 02/01/1994 - "This report presents the results of analysis of concentrations in plasma of adinazolam and its primary metabolite, N-desmethyladinazolam (NDMAD), determined as a part of a flexible-dose, double-blind study of the efficacy of adinazolam mesylate sustained release tablets in the treatment of panic disorder with agoraphobia. "
3.	Major Depressive Disorder (Major Depressive Disorders) 01/01/1986 - "A review of controlled studies of adinazolam mesylate in patients with major depressive disorder."

1.	Tablets
2.	mono-N-demethyladinazolam
3.	adinazolam
4.	Anti-Anxiety Agents (Anxiolytics)
5.	Antidepressive Agents (Antidepressants)
6.	Therapeutic Uses